Common Shares Outstanding: The number of class A shares currently held by investors.
Stoke Therapeutics, Inc. (STOK) had Common Shares Outstanding of 55.12M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$10.63M |
|
$-38.35M |
|
-- |
|
$10.63M |
|
$53.72M |
|
$-43.09M |
|
$3.47M |
|
$-39.62M |
|
$-39.62M |
|
$-38.35M |
|
$-38.35M |
|
$-38.35M |
|
$-38.35M |
|
$-43.09M |
|
$-43.26M |
|
58.61M |
|
58.61M |
|
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$272.44M |
|
$3.08M |
|
$87.83M |
|
$360.26M |
|
$41.73M |
|
-- |
|
$10.43M |
|
$52.16M |
|
$308.11M |
|
$308.11M |
|
$308.11M |
|
|
Common Shares Outstanding |
55.12M |
| Cash Flow Statement Financials | |
$76.04M |
|
$-125.75M |
|
$5.05M |
|
$128.78M |
|
$84.11M |
|
$-44.66M |
|
$22.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-405.30% |
|
-405.30% |
|
-- |
|
-372.70% |
|
-360.68% |
|
$75.60M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.98 |
|
91.74 |
|
-12.45% |
|
-12.45% |
|
-10.64% |
|
-12.45% |
|
$5.59 |
|
$1.29 |
|
$1.30 |
|